Patient Access Liaison, TEPEZZA-East Los Angeles

Patient Access Liaison - TEPEZZA (Rare Disease) Responsibilities Provide logistical, non-medical educational assistance to patients/caregivers and site-of-care staff (physicians, nurses, office managers, executives). Educate patients on TEPEZZA coverage, benefits, and steps for prior authorization; provide support to gain access to therapy. Secure written/electronic patient HIPAA for assigned geography. Develop relationships with patients/caregivers via phone, text, email, virtual, or in‑person. Provide co‑pay assistance, national foundation, and free drug program information as appropriate. Educate prescribers and sites of care on enrollment, coverage, prior authorization requirements, and coding/billing. Provide access and reimbursement education to physician offices and sites of care. Investigate access challenges pre‑ and post‑infusion (e.g., denied claims/claim reviews). Partner with Safety/PV and report AE's and product complaints through medical information. Work with cross‑functional teams and vendors to improve patient access and ongoing compliance. Adhere to professional standards and federal/state/local requirements. Qualifications Basic: Doctorate + 2 years (patient services and/or access/reimbursement) Master’s + 4 years Bachelor’s + 6 years Preferred: Scientific background Nursing/clinical background Buy‑and‑bill access/reimbursement experience Orphan/rare disease experience HIPAA & FDA familiarity OIG/Compliance adherence Handle difficult cases Team communication Respond within 24 hours when needed Strong analytical skills Microsoft Office proficiency Strong written and verbal communication Up to 50% travel Benefits (if eligible) Health/welfare plans, retirement/savings, life/disability, flexible spending, bonus/incentives (role‑dependent), stock‑based incentives, time‑off plans, and flexible work models (where applicable). Application Apply at careers.amgen.com; no application deadline (applications accepted until sufficient candidates are selected). #J-18808-Ljbffr Scorpion Therapeutics